Becker, R. E. & Shaskan, E. G. (1977) Platelet monoamine oxidase activity in schizophrenic patients. American Journal of Psychiatry, 134, 512–7.
Berrettini, W. H., Vogel, W. H. & Clouse, R. (1977) Platelet monoamine oxidase in chronic schizophrenia. American Journal of Psychiatry, 134, 805–6.
Breese, G. R. & Taylor, T. D. (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective destruction of catecholamine neurons. Journal of Pharmacology and Experimental Therapeutics, 174, 412–20.
Brockington, I., Crow, T. J., Johnstone, E. C. & Owen, F. (1976) An investigation of platelet monoamine oxidase activity in schizophrenia and schizoaffective psychosis. In Monoamine Oxidase and its Inhibition.
, pp 353–62. Amsterdam: Associated Scientific Publishers.
Carpenter, W. T., Murphy, D. L. & Wyatt, R. J. (1975) Platelet monoamine oxidase activity in acute schizophrenia. American Journal of Psychiatry, 132, 438–41.
Domino, E. F. & Khanna, S. S. (1976) Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients. American Journal of Psychiatry, 133, 323–6.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.
Friedman, E., Shopsin, B., Sathananthan, G. & Gershon, S. (1974) Blood platelet monoamine oxidase in psychiatric patients. American Journal of Psychiatry, 131, 1392–4.
Jarrott, B. (1974) Methods for analysing monoamine oxidase and catechol-O-methyltransferase in nervous tissue. In Research Methods in Neurochemistry, vol. 2, pp 377–88 (eds. N. Marks and R. Rodnight). New York: Plenum Press.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–75.
Mandell, A. J. & Segal, D. S. (1973) The psychobiology of dopamine and the methylated indoleamines with particular reference to psychiatry. In Biological Psychiatry (ed. J. Mendels), pp 89–112. New York: John Wiley & Sons.
Mann, J. J. & Chui, E. (1978) Platelet monoamine oxidase in Huntington's chorea. Journal of Neurology, Neurosurgery and Psychiatry, .
Meltzer, H. Y. & Stahl, S. M. (1974) Platelet monoamine oxidase and substrate preferences in schizophrenic patients. Research Communications in Chemical Pathology and Pharmacology, 7, 419–31.
Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. American Journal of Psychiatry, 128, 35–41.
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L. & Wyatt, R. J. (1976) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biological Medicine, 16, 254–65.
Murphy, D. L. & Wyatt, R. J. (1972) Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature, 238, 225–6.
Nies, A., Robinson, D. S., Harris, L. S. & Lamborn, K. R. (1974) Comparison of monoamine oxidase substrate activity in twins, schizophrenics, depressives and controls. Advances in Biochemical Psychopharmacology, 12, 59–70.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799–812.
Owen, F., Bourne, R., Crow, T. J., Johnstone, E. C., Bailey, A. R. & Hershon, H. I. (1976) Platelet monoamine oxidase in schizophrenia: an investigation in drug-free chronic hospitalized patients. Archives of General Psychiatry, 33, 1370–3.
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L. & Sylwester, D. (1971) Relation of sex and ageing to monoamine oxidase activity of human brain, plasma and platelets. Archives of General Psychiatry, 24, 536–9.
Sandler, M. & Reynolds, G. P. (1976) Does phenylethylamine cause schizophrenia ?
Lancet, i, 70–1.
Schildkraut, J. J., Herzog, J. M., Orsulak, P. J., Edelman, S. E., Shein, H. M. & Frazier, S. H. (1976) Reduced platelet monoamine oxidase activity in a sub-group of schizophrenic patients. American Journal of Psychiatry, 133, 438–40.
Schneider, K. (1959) Clinical Psychopathology. Translated by Hamilton, M.
New York: Grune and Stratton.
Smythies, J. R. (1976) Recent progress in schizophrenia research. Lancet, ii, 136–9.
Snyder, S. H., Banerjee, S. P., Yamamura, H. I. & Greenberg, D. (1974) Drugs, neurotransmitters and schizophrenia. Phenothiazines, amphetamines, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research. Science, 184, 1243–53.
Suluvan, J., Stanfield, C. N. & Dackis, C. (1977) Platelet MAO activity in schizophrenia and other psychiatric illnesses. American Journal of Psychiatry, 134, 1098–1103.
Takahashi, S., Yamane, H. & Tani, N. (1975) Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Folia Psychiatrica et Neurologica Japonica, 29, 207–14.
Wing, J. K. & Brown, G. W. (1970) Institutionalism and Schizophrenia.
London: Cambridge University Press.
Wyatt, R. J. & Murphy, D. L. (1976) Low platelet monoamine oxidase activity and schizophrenia. Schizophrenia Bulletin, 2, 77–89.
Zeller, E. A., Boshes, B., Arbit, J., Bieber, M., Blonsky, E. R., Dolkart, M. & Huprikar, S. V. (1976) Molecular biology of neurological and psychiatric disorders. 1. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. Journal of Neurotransmission, 39, 63–7.
Zeller, E. A., Boshes, B., Davis, J. M. & Thorner, M. (1975) Letter: molecular aberration in platelet monoamine oxidase in schizophrenia. Lancet, i, 1385.